Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR2B | P41595 | 7/20 | 0.40 |
| ▸ | HTR1A | P08908 | 3/20 | 0.40 |
| ▸ | PDPK1 | O15530 | 1/20 | 0.40 |
| ▸ | CCNT1 | O60563 | 1/20 | 0.40 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.40 |
| ▸ | CDK1 | P06493 | 1/20 | 0.40 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.40 |
| ▸ | PRKACA | P17612 | 1/20 | 0.40 |
| ▸ | CCNA2 | P20248 | 1/20 | 0.40 |
| ▸ | PRKACG | P22612 | 1/20 | 0.40 |
| ▸ | PRKACB | P22694 | 1/20 | 0.40 |
| ▸ | CDK2 | P24941 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | CDK9 | P50750 | 1/20 | 0.40 |
| ▸ | CCNA1 | P78396 | 1/20 | 0.40 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.40 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.40 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.40 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.40 |
| ▸ | HTR2A | P28223 | 11/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7866364 | 0.75 | HTR2C (0.61) | HTR2BHTR1APDPK1CCNT1CCNB2 | |
| SCHEMBL6625901 | 0.73 | HTR2C (0.41) | HTR2BHTR1AHTR2AHTR2CHTR1D | |
| SCHEMBL31357937 | 0.69 | HTR2A (0.71) | HTR2BHTR1APDPK1CCNT1CCNB2 | |
| SCHEMBL7866353 | 0.69 | SLC6A4 (0.64) | HTR1AHTR6KDM4EPOLBL3MBTL1 | |
| SCHEMBL30681636 | 0.69 | SLC6A4 (0.64) | HTR1AHTR6KDM4EPOLBL3MBTL1 | |
| SCHEMBL6497949 | 0.68 | TDO2 (0.46) | — | |
| SCHEMBL7205820 | 0.68 | SLC6A4 (0.53) | HTR1APDPK1CCNB2CDK1CCNB1 | |
| SCHEMBL9651757 | 0.65 | HTR2C (0.56) | HTR2BHTR1APDPK1CCNT1CCNB2 | |
| SCHEMBL29450053 | 0.65 | HTR2C (0.56) | HTR2BHTR1APDPK1CCNT1CCNB2 | |
| SCHEMBL4789469 | 0.64 | ALDH1A1 (0.35) | HTR2BHTR2AHTR2CGAAKDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250090554-A1 | A METHOD OF TREATING DEPRESSION BY IMMUNE MODULATION | MYND LIFE SCIENCES INC (CA) | 2025-03-20 | — | — | US | disclosed |
| US-20240366638-A1 | PSILOCYBIN ANALOGS FOR TREATING PSYCHOLOGICAL DISORDERS | SYNAPTIVE THERAPEUTICS, LLC | 2024-11-07 | — | — | US | disclosed |
| US-20230405026-A1 | A Method of Treating Depression by Immune Modulation | MYND LIFE SCIENCES INC (CA) | 2023-12-21 | — | — | US | disclosed |
| EP-0812826-A1 | 1H-indole and benzo(b)thiophene derivatives with 4-(1,2,3,6-tetra:hydro:pyridinyl)- and 4-piperidinyl-groups bound to the heterocyclic ring as inhibitors of serotonin reuptake | ELI LILLY AND COMPANY (US) | 1997-12-17 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240366638-A1 | PSILOCYBIN ANALOGS FOR TREATING PSYCHOLOGICAL DISORDERS | HTR1B, HTR2B, PNMT | HTR2B 2/4885HTR1A 8/4885PDPK1 1661/4885 |
| US-20230405026-A1 | A Method of Treating Depression by Immune Modulation | ABCF1, ABCF2, ABCB4 | HTR2B 1193/4885HTR1A 507/4885PDPK1 1526/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.